Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Filings indexed 1,608 across all filing types
Latest filing 2020-11-13 Regulatory Filings
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
109年第3季財務報告書 — 202003_1762_AI1.pdf
Regulatory Filings
2020-11-13 Chinese
109年第3季財務報告書 — 202002_1762_AI1.pdf
Regulatory Filings
2020-11-13 Chinese
109年第3季財務報告書 — 202001_1762_AI1.pdf
Regulatory Filings
2020-11-13 Chinese
109年第3季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the third quarter of the fiscal year 109 (which corresponds to 2020 in the Gregorian calendar). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific monetary amounts and accounting items. The presence of actual financial statements and substantive financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2393 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or a certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR).
2020-11-13 Chinese
109年第3季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data including consolidated comprehensive income statements for the third quarter of the fiscal year 109 (Taiwan calendar year, corresponding to 2020). It includes quarterly and year-to-date financial figures such as operating income, costs, gross profit, expenses, net profit, and earnings per share. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 3755 characters, which is sufficient to contain actual financial data rather than just an announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2020-11-13 Chinese
109年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items with amounts and percentages. The data is for the third quarter of the 109th year (Taiwan calendar), which corresponds to a quarterly period. The document length is 4379 characters, which is relatively short but contains substantive financial data, not just an announcement or a link to a report. The presence of detailed financial statements for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report rather than an Annual Report or just an announcement. There is no indication that this is a certification, proxy, or other type of filing. Therefore, the document is best classified as an Interim / Quarterly Report (IR).
2020-11-13 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.